Top Suppliers:I want be here

180144-61-0

180144-61-0 structure
180144-61-0 structure
  • Name: SR121566A
  • Chemical Name: SR121566A
  • CAS Number: 180144-61-0
  • Molecular Formula: C20H25N5O4S
  • Molecular Weight: 431.51
  • Catalog: Signaling Pathways Cytoskeleton Integrin
  • Create Date: 2018-01-11 11:25:47
  • Modify Date: 2024-01-02 15:20:51
  • SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.

Name SR121566A
Description SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
Related Catalog
Target

GP IIb-IIIa[1]

In Vivo SR121566A leads to dose-dependent increases in TTO, a statistically significant increase being observed at the doses of 0.3 mg/kg (473%) and 30 mg/kg (771%), respectively[2].
Animal Admin Male mice (26-30 g) are anesthetized, artificially ventilated, and placed on a heated jacket to control body temperature. A femoral vein is cannulated for i.v. injections. In thrombosis experiments, drugs including SR121566A are administered in 0.9% saline for intravenous studies (0.1 mL/30 g, 5 min before stimulation) and in water for oral studies (0.1 mL/30 g, 120 min before stimulation)[2].
References

[1]. Herault JP,et al. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thromb Haemost. 1998 Feb;79(2):383-8.

[2]. Lorrain J, et al. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel. J Pharmacol Exp Ther. 2004 Apr;309(1):235-40.

Molecular Formula C20H25N5O4S
Molecular Weight 431.51
Storage condition 2-8℃